Natco Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 1,252.30 | 1,219.50 | 575.60 |
| Operating Expense | 653 | 596.20 | 378.20 |
| Net Profit | 464.10 | 428.10 | 124.90 |
| Net Profit Margin | 37.06 | 35.10 | 21.70 |
| Earning Per Share | 25.91 | 23.90 | 6.97 |
| EBIDTA | 626.50 | 630.00 | 199.90 |
| Effective Tax Rate | 17.69 | 15.95 | 14.13 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 1252.30 |
| Operating Expense | 653.00 |
| Net Profit | 464.10 |
| Net Profit Margin | 37.06 |
| Earning Per Share | 25.91 |
| EBIDTA | 626.50 |
| Effective Tax Rate | 17.69 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 4,094.50 | 3,568.90 | 2,351 |
| Operating Expenses Annual | 1,950.20 | 1,931.90 | 1,506.30 |
| Operating Profit Annual | 2,465.60 | 1,741.70 | 930.20 |
| Interest Annual | 19.60 | 14.50 | 8.60 |
| Depreciation | 220 | 171.90 | 150.90 |
| Net Profit Annual | 1,850.40 | 1,306.60 | 637.10 |
| Tax Annual | 375.60 | 248.70 | 133.60 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 4,094.50 |
| Operating Expenses Annual | 1,950.20 |
| Operating Profit Annual | 2,465.60 |
| Interest Annual | 19.60 |
| Depreciation | 220 |
| Net Profit Annual | 1,850.40 |
| Tax Annual | 375.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 5.50 | 6.90 | 5.90 |
| Cash Flow from Operations | 1,662 | 1,196.40 | 784.40 |
| Cash Flow from Investing | -1,443.90 | -960.50 | -436.60 |
| Cash Flow from Financing | -212.40 | -237.30 | -346.80 |
| Cash Flow at the End | 11.20 | 5.50 | 6.90 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 5.50 |
| Cash Flow from Operations | 1,662 |
| Cash Flow from Investing | -1,443.90 |
| Cash Flow from Financing | -212.40 |
| Cash Flow at the End | 11.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 60.22 | 48.80 | 39.57 |
| PBIT Margin (%) | 54.84 | 43.99 | 33.15 |
| PBT Margin (%) | 52.04 | 40.96 | 29.30 |
| Net PROFIT Margin (%) | 45.19 | 36.61 | 27.10 |
| Return On Networth / Equity (%) | 28.63 | 25.38 | 14.33 |
| Return On Networth /Employed (%) | 32.75 | 28.58 | 16.17 |
| Return On Assets (%) | 27.12 | 23.80 | 13.28 |
| Total Debt / Equity (X) | 0.05 | 0.05 | 0.06 |
| Asset Turnover Ratio (%) | 0.60 | 0.65 | 0.49 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 60.22 |
| PBIT Margin (%) | 54.84 |
| PBT Margin (%) | 52.04 |
| Net PROFIT Margin (%) | 45.19 |
| Return On Networth / Equity (%) | 28.63 |
| Return On Networth /Employed (%) | 32.75 |
| Return On Assets (%) | 27.12 |
| Total Debt / Equity (X) | 0.05 |
| Asset Turnover Ratio (%) | 0.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 2,516.80 | 2,286.70 | 2,233.80 |
| Total Current Assets Annual | 4,688 | 3,410.40 | 2,494.70 |
| Non Current Assets Annual | 3,581.90 | 3,143.60 | 2,893.20 |
| Total Shareholders Funds Annual | 7,333.90 | 5,592.30 | 4,702 |
| Total Assets Annual | 8,269.90 | 6,554 | 5,387.90 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 2,516.80 |
| Total Current Assets Annual | 4,688 |
| Non Current Assets Annual | 3,581.90 |
| Total Shareholders Funds Annual | 7,333.90 |
| Total Assets Annual | 8,269.90 |
EPS (INR)
Expected
26.85
Reported
26.84
Surprise
-0.04%
Mar 2025
EPS beaten by -0.04%
Dec 2024
EPS beaten by -0.09%
Sep 2024
EPS beaten by 0.00%
